.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Evaluating Therapeutic Options in Chronic Lymphocytic Leukemia

EP. 1: What Testing is Done Alongside a Diagnosis of CLL?

December 27th 2018

EP. 2: Chronic Lymphocytic Leukemia: Selecting Initial Therapy

December 27th 2018

EP. 3: Understanding the Timing of Therapy in CLL

December 27th 2018

EP. 4: Relapsed CLL: Factors in Choosing Therapy

December 27th 2018

EP. 5: Impacting CLL Management With Lifestyle Modification

December 27th 2018

EP. 6: Moving the Paradigm of CLL Management Forward

December 27th 2018

EP. 7: Confirming a Diagnosis of CLL

December 27th 2018

EP. 8: Role of Watchful Waiting in CLL

December 27th 2018

EP. 9: Indications for Initiating Therapy in CLL

December 27th 2018

EP. 10: Tests Used to Inform Treatment Decisions in CLL

December 27th 2018

EP. 11: Chemoimmunotherapy in CLL

December 27th 2018

EP. 12: Clinical Trial Participation in CLL

December 27th 2018

EP. 13: Considering a Clinical Trial for CLL Treatment

December 27th 2018

EP. 14: Danise: Experience With Venetoclax Targeted Therapy

December 27th 2018

EP. 15: Managing Side Events From Targeted Therapy for CLL

December 27th 2018

EP. 16: CLL Management: Establishing a Network of Support

December 27th 2018

EP. 17: Navigating Through CLL Treatment

December 27th 2018

Latest News

Living Well Beyond Bladder Cancer With Support

Expert Discusses Effects of a Bladder Cancer Diagnosis on Caregivers and the Support Available to Them

Patients Can Help Move the Needle Forward in Bladder Cancer Clinical Trials With Participation

Having Open and Honest Conversations With Oncologists Aids in Patient-Physician Communication in Bladder Cancer

View More Latest News